Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nutrinova is a global leader in the production of high-intensity sweeteners and food preservatives, serving the food, beverage, and pharmaceutical industries. The company is best known for inventing Sunett (acesulfame potassium), a widely used calorie-free sweetener, and for its extensive portfolio of sorbates used to maintain product freshness. Originally a part of Hoechst and later a business unit of Celanese, Nutrinova became a joint venture in 2023 following the acquisition of a 70% stake by Mitsui & Co. The company operates manufacturing facilities in Germany and China, adhering to stringent quality standards such as GMP for pharmaceutical-grade ingredients. Nutrinova's products are essential components in thousands of consumer goods, providing taste enhancement and shelf-life stability.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nutrinova.